A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Clinical trial NCT07144280 · RECRUITING

Trial details

NCT number: NCT07144280
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Non-small Cell Carcinoma Non-Small Cell Lung Cancer Metastatic Non-Small Cell Lung Carcinoma

Start date: 2025-09-29
Primary completion: 2028-03-10
Enrollment: 680

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.